Upcoming SAA research: cyclosporine and eltrombopag

Eltrombopag for CMML patients with thrombocytopeniaПодробнее

Danielle M. TownsleyПодробнее

Eltrombopag Trial and Treatment DiscontinuationПодробнее

First-line treatment of SAA: towards a new standard of care?Подробнее

ASH 2016: Aplastic Anemia Research UpdateПодробнее

Relapse Prevention in Aplastic AnemiaПодробнее

EBMT 2020 Van Bekkum AwardПодробнее

Highlights from ASH 2016: Aplastic Anemia 2/15/17Подробнее

Updates on Aplastic Anemia and PNH from ASH2021, ASCO2022, and EHA2022Подробнее

Treating Children with Aplastic AnemiaПодробнее

Aplastic Anemia Treatment Options (Co-Chair Summary)Подробнее

What’s New in Aplastic Anemia and PNH? Important Findings from ASH 2018Подробнее

Webinar: Moderate, Severe, Very Severe Aplastic Anemia 2018Подробнее

Unrelated transplantation vs. immunosuppression for SAAПодробнее

8th Seattle Patient Conference - Aplastic AnemiaПодробнее

2015 SA Vaccinology Update 1/3Подробнее

2024 CRE Expert Webinar One – Aplastic Anaemia GuidelinesПодробнее

A Phase 1 Trial of Cyclosporine for Hospitalized Patients with COVID-19Подробнее

Haplo vs. cord for SAAПодробнее